Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Relationship between Risk Factor Control and Compliance with a Lifestyle Modification Program in the Stenting Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis Trial.

Turan TN, Al Kasab S, Nizam A, Lynn MJ, Harrell J, Derdeyn CP, Fiorella D, Janis LS, Lane BF, Montgomery J, Chimowitz MI; SAMMPRIS Investigators.

J Stroke Cerebrovasc Dis. 2018 Mar;27(3):801-805. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.017. Epub 2017 Nov 21.

PMID:
29169967
2.

Effects of Spaceflight on Astronaut Brain Structure as Indicated on MRI.

Roberts DR, Albrecht MH, Collins HR, Asemani D, Chatterjee AR, Spampinato MV, Zhu X, Chimowitz MI, Antonucci MU.

N Engl J Med. 2017 Nov 2;377(18):1746-1753. doi: 10.1056/NEJMoa1705129.

3.

Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).

Derdeyn CP, Fiorella D, Lynn MJ, Turan TN, Cotsonis GA, Lane BF, Montgomery J, Janis LS, Chimowitz MI; SAMMPRIS Investigators.

Stroke. 2017 Jun;48(6):1501-1506. doi: 10.1161/STROKEAHA.116.014537. Epub 2017 Apr 28.

PMID:
28455321
4.

Stroke Caused by Atherosclerosis of the Major Intracranial Arteries.

Banerjee C, Chimowitz MI.

Circ Res. 2017 Feb 3;120(3):502-513. doi: 10.1161/CIRCRESAHA.116.308441. Review.

5.

Postprandial Clearance of Oxidized Low-Density Lipoprotein in Patients with Stroke Due to Atherosclerosis.

Al Kasab S, Cassarly C, Le NA, Martin R, Brinley J, Chimowitz MI, Turan TN.

J Stroke Cerebrovasc Dis. 2017 Mar;26(3):488-493. doi: 10.1016/j.jstrokecerebrovasdis.2016.12.006. Epub 2017 Jan 6.

PMID:
28089094
6.

Relationship between risk factor control and vascular events in the SAMMPRIS trial.

Turan TN, Nizam A, Lynn MJ, Egan BM, Le NA, Lopes-Virella MF, Hermayer KL, Harrell J, Derdeyn CP, Fiorella D, Janis LS, Lane B, Montgomery J, Chimowitz MI.

Neurology. 2017 Jan 24;88(4):379-385. doi: 10.1212/WNL.0000000000003534. Epub 2016 Dec 21.

7.

Angioplasty and Stenting.

Leung TW, Wabnitz AM, Miao Z, Chimowitz MI.

Front Neurol Neurosci. 2016;40:152-163. Epub 2016 Dec 2. Review.

PMID:
27960179
8.

Is There Benefit from Stenting on Cognitive Function in Intracranial Atherosclerosis?

Turan TN, Smock A, Cotsonis G, Bachman D, Al Kasab S, Lynn MJ, Nizham A, Derdeyn CP, Fiorella D, Janis S, Lane B, Montgomery J, Chimowitz MI; SAMMPRIS Investigators.

Cerebrovasc Dis. 2017;43(1-2):31-35. doi: 10.1159/000450964. Epub 2016 Nov 5.

9.

Impact of the New American Heart Association/American Stroke Association Definition of Stroke on the Results of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial.

Al Kasab S, Lynn MJ, Turan TN, Derdeyn CP, Fiorella D, Lane BF, Janis LS, Chimowitz MI; SAMMPRIS Investigators.

J Stroke Cerebrovasc Dis. 2017 Jan;26(1):108-115. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.038. Epub 2016 Oct 17.

PMID:
27765556
10.

Characterization of intracranial atherosclerotic stenosis using high-resolution MRI study--rationale and design.

Turan TN, LeMatty T, Martin R, Chimowitz MI, Rumboldt Z, Spampinato MV, Stalcup S, Adams RJ, Brown T.

Brain Behav. 2015 Sep 25;5(12):e00397. doi: 10.1002/brb3.397. eCollection 2015 Dec.

11.

Factors Associated With Recurrent Ischemic Stroke in the Medical Group of the SAMMPRIS Trial.

Waters MF, Hoh BL, Lynn MJ, Kwon HM, Turan TN, Derdeyn CP, Fiorella D, Khanna A, Sheehan TO, Lane BF, Janis S, Montgomery J, Chimowitz MI; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial Investigators.

JAMA Neurol. 2016 Mar;73(3):308-15. doi: 10.1001/jamaneurol.2015.4315. Erratum in: JAMA Neurol. 2016 Apr;73(4):481.

12.

Frequency, Risk Factors, and Outcome of Coexistent Small Vessel Disease and Intracranial Arterial Stenosis: Results From the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) Trial.

Kwon HM, Lynn MJ, Turan TN, Derdeyn CP, Fiorella D, Lane BF, Montgomery J, Janis LS, Rumboldt Z, Chimowitz MI; SAMMPRIS Investigators.

JAMA Neurol. 2016 Jan;73(1):36-42. doi: 10.1001/jamaneurol.2015.3145.

13.

Enrollment volume effect on risk factor control and outcomes in the SAMMPRIS trial.

Chiu D, Klucznik RP, Turan TN, Lynn MJ, McCane CD, Katz LB, Nizam A, Derdeyn CP, Fiorella D, Lane BF, Montgomery J, Janis S, Chimowitz MI.

Neurology. 2015 Dec 15;85(24):2090-7. doi: 10.1212/WNL.0000000000002191. Epub 2015 Nov 11.

14.

Does the Stenting Versus Aggressive Medical Therapy Trial Support Stenting for Subgroups With Intracranial Stenosis?

Lutsep HL, Lynn MJ, Cotsonis GA, Derdeyn CP, Turan TN, Fiorella D, Janis LS, Lane BF, Montgomery J, Chimowitz MI; SAMMPRIS Investigators.

Stroke. 2015 Nov;46(11):3282-4. doi: 10.1161/STROKEAHA.115.009846. Epub 2015 Sep 17. Erratum in: Stroke. 2015 Nov;46(11):e248.

15.

Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID?

Chaturvedi S, Turan TN, Lynn MJ, Derdeyn CP, Fiorella D, Janis LS, Chimowitz MI; SAMMPRIS Trial Investigators.

Stroke. 2015 Sep;46(9):2562-7. doi: 10.1161/STROKEAHA.115.009656. Epub 2015 Aug 6.

16.

Yet again no benefit of stenting over medical therapy.

Turan TN, Chimowitz MI.

Lancet Neurol. 2015 Jun;14(6):565-6. doi: 10.1016/S1474-4422(15)00049-6. Epub 2015 Apr 20. No abstract available.

PMID:
25908091
17.

Endovascular therapy for atherosclerotic intracranial arterial stenosis: back to the drawing board.

Chimowitz MI, Derdeyn CP.

JAMA. 2015 Mar 24-31;313(12):1219-20. doi: 10.1001/jama.2015.1276. No abstract available.

PMID:
25803345
18.

Outcome in patients previously on antithrombotic therapy in the SAMMPRIS trial: subgroup analysis.

Lutsep HL, Barnwell SL, Larsen DT, Lynn MJ, Hong M, Turan TN, Derdeyn CP, Fiorella D, Janis LS, Chimowitz MI; SAMMPRIS Investigators.

Stroke. 2015 Mar;46(3):775-9. doi: 10.1161/STROKEAHA.114.007752. Epub 2015 Jan 15.

19.

Infarct patterns, collaterals and likely causative mechanisms of stroke in symptomatic intracranial atherosclerosis.

López-Cancio E, Matheus MG, Romano JG, Liebeskind DS, Prabhakaran S, Turan TN, Cotsonis GA, Lynn MJ, Rumboldt Z, Chimowitz MI.

Cerebrovasc Dis. 2014;37(6):417-22. doi: 10.1159/000362922. Epub 2014 Jul 4.

20.

Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.

Kernan WN, Ovbiagele B, Black HR, Bravata DM, Chimowitz MI, Ezekowitz MD, Fang MC, Fisher M, Furie KL, Heck DV, Johnston SC, Kasner SE, Kittner SJ, Mitchell PH, Rich MW, Richardson D, Schwamm LH, Wilson JA; American Heart Association Stroke Council, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Peripheral Vascular Disease.

Stroke. 2014 Jul;45(7):2160-236. doi: 10.1161/STR.0000000000000024. Epub 2014 May 1. Erratum in: Stroke. 2015 Feb;46(2):e54.

PMID:
24788967
21.

Game changer for endovascular treatment of acute ischemic stroke?

Chimowitz MI.

J Neurointerv Surg. 2014 May;6(4):252-3. doi: 10.1136/neurintsurg-2014-011187. Epub 2014 Mar 12. No abstract available.

PMID:
24623835
22.

Noninvasive fractional flow on MRA predicts stroke risk of intracranial stenosis.

Liebeskind DS, Kosinski AS, Lynn MJ, Scalzo F, Fong AK, Fariborz P, Chimowitz MI, Feldmann E.

J Neuroimaging. 2015 Jan-Feb;25(1):87-91. doi: 10.1111/jon.12101. Epub 2014 Mar 5.

23.

Intracranial stenosis: impact of randomized trials on treatment preferences of US neurologists and neurointerventionists.

Turan TN, Cotsonis G, Lynn MJ, Wooley RH, Swanson S, Williams JE, Stern BJ, Derdeyn CP, Fiorella D, Chimowitz MI.

Cerebrovasc Dis. 2014;37(3):203-11. doi: 10.1159/000358120. Epub 2014 Feb 19.

24.

Is calcification of intracranial arteries important and how?

Chimowitz MI, Caplan LR.

JAMA Neurol. 2014 Apr;71(4):401-2. doi: 10.1001/jamaneurol.2013.6224. No abstract available.

PMID:
24535614
25.

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial.

Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, Montgomery J, Nizam A, Lane BF, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Lynch JR, Zaidat OO, Rumboldt Z, Cloft HJ; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators.

Lancet. 2014 Jan 25;383(9914):333-41. doi: 10.1016/S0140-6736(13)62038-3. Epub 2013 Oct 26.

26.

In reply: Is there a contribution of anesthesia to the outcome of the SAMMPRIS trial?

Derdeyn CP, Fiorella D, Chimowitz MI.

Neurosurgery. 2014 Feb;74(2):E235-6. doi: 10.1227/NEU.0000000000000227. No abstract available.

27.

Atherosclerotic intracranial arterial stenosis: risk factors, diagnosis, and treatment.

Holmstedt CA, Turan TN, Chimowitz MI.

Lancet Neurol. 2013 Nov;12(11):1106-14. doi: 10.1016/S1474-4422(13)70195-9. Review.

28.

The challenge of stroke prevention with intracranial arterial stenosis.

Turan TN, Smock A, Chimowitz MI.

Curr Cardiol Rep. 2013 Dec;15(12):422. doi: 10.1007/s11886-013-0422-y. Review.

29.

The Feinberg Award Lecture 2013: treatment of intracranial atherosclerosis: learning from the past and planning for the future.

Chimowitz MI.

Stroke. 2013 Sep;44(9):2664-9. doi: 10.1161/STROKEAHA.113.001290. Epub 2013 Jul 2. No abstract available.

30.

Intracranial stenting: SAMMPRIS.

Derdeyn CP, Fiorella D, Lynn MJ, Turan TN, Lane BF, Janis LS, Chimowitz MI.

Stroke. 2013 Jun;44(6 Suppl 1):S41-4. doi: 10.1161/STROKEAHA.111.000370. Review. No abstract available.

31.

MUSC's comprehensive stroke program: changing what's possible in stroke care across South Carolina.

Magarik JA, Jauch EC, Patel SJ, Adams RJ, Turner RD, Chaudry MI, Chalela JA, Hays A, Chimowitz MI, Turan TN, Holmstedt CA, Debenham E, Lackland DT, Turk AS.

J S C Med Assoc. 2012 Oct-Dec;108(5):128-31. Review. No abstract available.

32.

Endovascular treatment for acute ischemic stroke--still unproven.

Chimowitz MI.

N Engl J Med. 2013 Mar 7;368(10):952-5. doi: 10.1056/NEJMe1215730. Epub 2013 Feb 8. No abstract available.

PMID:
23394477
33.

Mechanisms of stroke after intracranial angioplasty and stenting in the SAMMPRIS trial.

Derdeyn CP, Fiorella D, Lynn MJ, Rumboldt Z, Cloft HJ, Gibson D, Turan TN, Lane BF, Janis LS, Chimowitz MI; Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial Investigators.

Neurosurgery. 2013 May;72(5):777-95; discussion 795. doi: 10.1227/NEU.0b013e318286fdc8.

34.

Response to critique of the Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial by Abou-Chebl and Steinmetz.

Chimowitz MI, Fiorella D, Derdeyn CP, Turan TN, Lane BF, Janis S, Lynn MJ.

Stroke. 2012 Oct;43(10):2806-9. No abstract available.

35.

Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.

Turan TN, Lynn MJ, Nizam A, Lane B, Egan BM, Le NA, Lopes-Virella MF, Hermayer KL, Benavente O, White CL, Brown WV, Caskey MF, Steiner MR, Vilardo N, Stufflebean A, Derdeyn CP, Fiorella D, Janis S, Chimowitz MI; SAMMPRIS Investigators.

Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):e51-60. No abstract available.

36.

Detailed analysis of periprocedural strokes in patients undergoing intracranial stenting in Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis (SAMMPRIS).

Fiorella D, Derdeyn CP, Lynn MJ, Barnwell SL, Hoh BL, Levy EI, Harrigan MR, Klucznik RP, McDougall CG, Pride GL Jr, Zaidat OO, Lutsep HL, Waters MF, Hourihane JM, Alexandrov AV, Chiu D, Clark JM, Johnson MD, Torbey MT, Rumboldt Z, Cloft HJ, Turan TN, Lane BF, Janis LS, Chimowitz MI; SAMMPRIS Trial Investigators.

Stroke. 2012 Oct;43(10):2682-8. Epub 2012 Sep 13.

37.

Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial.

Derdeyn CP, Fiorella D, Lynn MJ, Barnwell SL, Zaidat OO, Meyers PM, Gobin YP, Dion J, Lane BF, Turan TN, Janis LS, Chimowitz MI; SAMMPRIS Trial Investigators.

J Neurointerv Surg. 2013 Nov;5(6):528-33. doi: 10.1136/neurintsurg-2012-010504. Epub 2012 Sep 12.

38.

Utilization of CT perfusion patient selection for mechanical thrombectomy irrespective of time: a comparison of functional outcomes and complications.

Turk AS, Nyberg EM, Chaudry MI, Turner RD, Magarik JA, Nicholas JS, Holmstedt CA, Chalela JA, Hays A, Lazaridis C, Chimowitz MI, Turan TN, Adams RJ, Jauch EC.

J Neurointerv Surg. 2013 Nov;5(6):518-22. doi: 10.1136/neurintsurg-2012-010452. Epub 2012 Aug 30.

PMID:
22935349
39.

Risk factors and outcome of patients with symptomatic intracranial stenosis presenting with lacunar stroke.

Khan A, Kasner SE, Lynn MJ, Chimowitz MI; Warfarin Aspirin Symptomatic Intracranial Disease (WASID) Trial Investigators.

Stroke. 2012 May;43(5):1230-3. doi: 10.1161/STROKEAHA.111.641696. Epub 2012 Feb 23.

40.

Stenting versus aggressive medical therapy for intracranial arterial stenosis.

Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, Chiu D, Klucznik RP, Clark JM, McDougall CG, Johnson MD, Pride GL Jr, Torbey MT, Zaidat OO, Rumboldt Z, Cloft HJ; SAMMPRIS Trial Investigators.

N Engl J Med. 2011 Sep 15;365(11):993-1003. doi: 10.1056/NEJMoa1105335. Epub 2011 Sep 7. Erratum in: N Engl J Med. 2012 Jul 5;367(1):93.

41.

Design of the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis trial.

Chimowitz MI, Lynn MJ, Turan TN, Fiorella D, Lane BF, Janis S, Derdeyn CP; SAMMPRIS Investigators.

J Stroke Cerebrovasc Dis. 2011 Jul-Aug;20(4):357-68. doi: 10.1016/j.jstrokecerebrovasdis.2011.05.001.

42.

Collaterals dramatically alter stroke risk in intracranial atherosclerosis.

Liebeskind DS, Cotsonis GA, Saver JL, Lynn MJ, Turan TN, Cloft HJ, Chimowitz MI; Warfarin-Aspirin Symptomatic Intracranial Disease (WASID) Investigators.

Ann Neurol. 2011 Jun;69(6):963-74. doi: 10.1002/ana.22354. Epub 2011 Mar 17.

43.

Collateral circulation in symptomatic intracranial atherosclerosis.

Liebeskind DS, Cotsonis GA, Saver JL, Lynn MJ, Cloft HJ, Chimowitz MI; Warfarin–Aspirin Symptomatic Intracranial Disease (WASID) Investigators.

J Cereb Blood Flow Metab. 2011 May;31(5):1293-301. doi: 10.1038/jcbfm.2010.224. Epub 2010 Dec 15.

44.

10 questions about intracranial atherosclerotic stenosis.

Turan TN, Chimowitz MI.

Neurologist. 2010 Nov;16(6):400-5. doi: 10.1097/NRL.0b013e3181e52b8c.

PMID:
21150394
45.

Risk factors associated with severity and location of intracranial arterial stenosis.

Turan TN, Makki AA, Tsappidi S, Cotsonis G, Lynn MJ, Cloft HJ, Chimowitz MI; WASID Investigators.

Stroke. 2010 Aug;41(8):1636-40. doi: 10.1161/STROKEAHA.110.584672. Epub 2010 Jul 8.

46.

Intraplaque hemorrhage in symptomatic intracranial atherosclerotic disease.

Turan TN, Bonilha L, Morgan PS, Adams RJ, Chimowitz MI.

J Neuroimaging. 2011 Apr;21(2):e159-61. doi: 10.1111/j.1552-6569.2009.00442.x.

PMID:
19909397
47.

Current status of the management of symptomatic intracranial atherosclerotic disease: the rationale for a randomized trial of medical therapy and intracranial stenting.

Fiorella D, Turan TN, Derdeyn CP, Chimowitz MI.

J Neurointerv Surg. 2009 Jul;1(1):35-9. doi: 10.1136/jnis.2009.000125. Epub 2009 Jul 3. Review.

PMID:
21994103
48.

Treatment of atherosclerotic intracranial arterial stenosis.

Turan TN, Derdeyn CP, Fiorella D, Chimowitz MI.

Stroke. 2009 Jun;40(6):2257-61. doi: 10.1161/STROKEAHA.108.537589. Epub 2009 Apr 30. Review. No abstract available.

49.

Causes and severity of ischemic stroke in patients with symptomatic intracranial arterial stenosis.

Famakin BM, Chimowitz MI, Lynn MJ, Stern BJ, George MG; WASID Trial Investigators.

Stroke. 2009 Jun;40(6):1999-2003. doi: 10.1161/STROKEAHA.108.546150. Epub 2009 Apr 30.

50.

Risk factors associated with major cerebrovascular complications after intracranial stenting.

Nahab F, Lynn MJ, Kasner SE, Alexander MJ, Klucznik R, Zaidat OO, Chaloupka J, Lutsep H, Barnwell S, Mawad M, Lane B, Chimowitz MI; NIH Multicenter Wingspan Intracranial Stent Registry Study Group.

Neurology. 2009 Jun 9;72(23):2014-9. doi: 10.1212/01.wnl.0b013e3181a1863c. Epub 2009 Mar 18.

Supplemental Content

Loading ...
Support Center